Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cryolife (CRY)

Cryolife (CRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cryolife 1655 Roberts Boulevard N.W Kennesaw GA 30144 USA

www.cryolife.com P: 770-419-3355

Description:

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries. It operates throughout the U.S. and internationally. CryoLife manufactures and distributes BioGlue Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world. CryoLife's BioFoam Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical. CryoLife distributes PerClot, a powdered hemostat, in Europe and other select international countries.

Key Statistics

Overview:

Market Capitalization, $K 703,220
Shares Outstanding, K 39,330
Annual Sales, $ 253,230 K
Annual Net Income, $ -16,680 K
Last Quarter Sales, $ 72,210 K
Last Quarter Net Income, $ 10,580 K
60-Month Beta 1.53
% of Insider Shareholders 4.50%
% of Institutional Shareholders 81.57%
Float, K 37,560
% Float 95.50%

Growth:

1-Year Return -29.33%
3-Year Return -36.07%
5-Year Return -3.61%
5-Year Revenue Growth 73.58%
5-Year Earnings Growth -16.67%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings -0.08 on 04/29/21
Latest Earnings Date 02/10/22
Earnings Per Share ttm 0.32
EPS Growth vs. Prev Qtr 533.33%
EPS Growth vs. Prev Year 100.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.030 on 12/09/15
Next Ex-Dividends Date 12/09/15
Dividend Payable Date 12/18/15
Dividend Payout Ratio 0.00%
Most Recent Split 3-2 on 12/28/00

CRY Ratios

Ratio
Price/Earnings ttm 55.09
Price/Earnings forward 83.81
Price/Earnings to Growth N/A
Return-on-Equity % 4.24%
Return-on-Assets % 1.63%
Profit Margin % -6.59%
Debt/Equity 0.99
Price/Sales 2.44
Price/Cash Flow 22.86
Price/Book 2.26
Book Value/Share 7.92
Interest Coverage -0.03

CRY Dividends

Date Value
12/09/15 $0.0300
09/09/15 $0.0300
06/10/15 $0.0300
03/11/15 $0.0300
12/10/14 $0.0300
09/10/14 $0.0300
06/11/14 $0.0300
03/12/14 $0.0275
12/11/13 $0.0275
09/11/13 $0.0275
06/12/13 $0.0275
03/12/13 $0.0250
12/12/12 $0.0250
09/12/12 $0.0250
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar